BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31420752)

  • 1. Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics.
    Khan I; Joshi G; Nakhate KT; Ajazuddin ; Kumar R; Gupta U
    Pharm Res; 2019 Aug; 36(10):149. PubMed ID: 31420752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
    Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
    Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD-340 functionalized doxorubicin-loaded nanoparticle induces apoptosis and reduces tumor volume along with drug-related cardiotoxicity in mice.
    Mondal L; Mukherjee B; Das K; Bhattacharya S; Dutta D; Chakraborty S; Pal MM; Gaonkar RH; Debnath MC
    Int J Nanomedicine; 2019; 14():8073-8094. PubMed ID: 31632019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E-Jet 3D-Printed Scaffolds as Sustained Multi-Drug Delivery Vehicles in Breast Cancer Therapy.
    Qiao X; Yang Y; Huang R; Shi X; Chen H; Wang J; Chen Y; Tan Y; Tan Z
    Pharm Res; 2019 Nov; 36(12):182. PubMed ID: 31741089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled nanoparticles of reduction-sensitive poly (lactic-co-glycolic acid)-conjugated chondroitin sulfate A for doxorubicin delivery: preparation, characterization and evaluation.
    Wang XF; Ren J; He HQ; Liang L; Xie X; Li ZX; Zhao JG; Yu JM
    Pharm Dev Technol; 2019 Jul; 24(6):794-802. PubMed ID: 30907676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of a new quinoxaline derivative in PLGA alters the pattern of its anticancer potency and induces apoptosis.
    Saad EA; Waly HM
    Cancer Chemother Pharmacol; 2019 Apr; 83(4):649-658. PubMed ID: 30648201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterisation and in vitro and in vivo evaluation of CD44-targeted chondroitin sulphate-conjugated doxorubicin PLGA nanoparticles.
    Liu P; Chen N; Yan L; Gao F; Ji D; Zhang S; Zhang L; Li Y; Xiao Y
    Carbohydr Polym; 2019 Jun; 213():17-26. PubMed ID: 30879657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na
    Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
    Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of pH-responsive PLGA(UCNPs/DOX) nanocapsules with upconversion luminescence for drug delivery.
    Zhao J; Yang H; Li J; Wang Y; Wang X
    Sci Rep; 2017 Dec; 7(1):18014. PubMed ID: 29269874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles.
    Kiruthiga C; Balan DJ; Prasath NH; Manikandakrishnan M; Jafni S; Prabhu NM; Pandian SK; Devi KP
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5131-5144. PubMed ID: 38240783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies.
    Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I
    Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
    Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release.
    Yoo HS; Oh JE; Lee KH; Park TG
    Pharm Res; 1999 Jul; 16(7):1114-8. PubMed ID: 10450940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and in vitro/in vivo evaluation of doxorubicin-loaded poly[lactic-co-glycol acid] microspheres using electrospray method for sustained drug delivery and potential intratumoral injection.
    Hsu MY; Huang YT; Weng CJ; Chen CM; Su YF; Chu SY; Tseng JH; Wu RC; Liu SJ
    Colloids Surf B Biointerfaces; 2020 Jun; 190():110937. PubMed ID: 32155454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: A novel strategy.
    Liu Y; Liu Q; Liu Y; Ju F; Ma Q; He Q
    J Photochem Photobiol B; 2019 Oct; 199():111619. PubMed ID: 31622787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-responsive high stability polymeric nanoparticles for targeted delivery of anticancer therapeutics.
    Palanikumar L; Al-Hosani S; Kalmouni M; Nguyen VP; Ali L; Pasricha R; Barrera FN; Magzoub M
    Commun Biol; 2020 Mar; 3(1):95. PubMed ID: 32127636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs.
    Lai YH; Chiang CS; Hsu CH; Cheng HW; Chen SY
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
    Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
    Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.